iBio Inc (NASDAQ:IBIO)’s traded shares stood at 0.5 million during the last session, with the company’s beta value hitting 0.97. At the close of trading,
Orion Group Holdings Inc (NYSE:ORN)’s traded shares stood at 0.49 million during the last session, with the company’s beta value hitting 0.76. At the close
Telomir Pharmaceuticals Inc (NASDAQ:TELO)’s traded shares stood at 0.67 million during the last session, with the company’s beta value hitting -0.99. At the close of
Upstream Bio Inc (NASDAQ:UPB)’s traded shares stood at 0.74 million during the last session. At the close of trading, the stock’s price was $7.62, to
Moleculin Biotech Inc (NASDAQ:MBRX)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 2.16.The MBRX share’s 52-week high
GlycoMimetics Inc (NASDAQ:GLYC)’s traded shares stood at 0.6 million during the last session, with the company’s beta value hitting 1.63. At the close of trading,
Forge Global Holdings Inc (NYSE:FRGE)’s traded shares stood at 0.74 million during the last session, with the company’s beta value hitting 2.36. At the close
Eve Holding Inc (NYSE:EVEX)’s traded shares stood at 0.76 million during the last session, with the company’s beta value hitting 0.52. At the close of
Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares stood at 0.56 million during the last session, with the company’s beta value hitting 1.00. At the close of
Astria Therapeutics Inc (NASDAQ:ATXS)’s traded shares stood at 0.86 million during the last session, with the company’s beta value hitting 0.60. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
